CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Core Laboratories - CLBus CFD

20.73
3.6%
0.23
Low: 20.33
High: 20.96
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.23
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Core Laboratories NV ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 20.01
Open* 20.42
1-Year Change* -15.3%
Day's Range* 20.33 - 20.33
52 wk Range 13.19-35.8287
Average Volume (10 days) 0.40041
Average Volume (3 months) 9.38362
Market Cap 979.362
P/E Ratio 64.5378
Shares Outstanding 46371300
Revenue 487.303
EPS 0.32725
Dividend (Yield %) 0.18939
Beta 2.64002
Next Earnings Date Jan 31, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 29, 2022 20.73 0.50 2.47% 20.23 20.99 20.22
Nov 28, 2022 20.01 -0.07 -0.35% 20.08 20.75 19.99
Nov 25, 2022 20.85 0.29 1.41% 20.56 21.28 20.51
Nov 23, 2022 20.92 0.25 1.21% 20.67 21.00 20.28
Nov 22, 2022 21.09 0.50 2.43% 20.59 21.38 20.38
Nov 21, 2022 20.43 -0.55 -2.62% 20.98 20.99 19.78
Nov 18, 2022 21.70 -0.12 -0.55% 21.82 21.83 21.28
Nov 17, 2022 22.28 0.88 4.11% 21.40 22.47 21.36
Nov 16, 2022 22.22 -0.20 -0.89% 22.42 22.63 22.15
Nov 15, 2022 22.95 0.56 2.50% 22.39 23.15 21.94
Nov 14, 2022 22.38 -0.15 -0.67% 22.53 23.49 22.25
Nov 11, 2022 22.86 1.82 8.65% 21.04 23.11 21.04
Nov 10, 2022 20.46 -0.13 -0.63% 20.59 20.95 20.00
Nov 9, 2022 20.18 -0.02 -0.10% 20.20 20.71 19.93
Nov 8, 2022 21.13 0.47 2.27% 20.66 21.37 20.47
Nov 7, 2022 20.91 0.26 1.26% 20.65 21.20 20.57
Nov 4, 2022 20.67 0.13 0.63% 20.54 21.61 20.32
Nov 3, 2022 20.22 1.42 7.55% 18.80 20.28 18.66
Nov 2, 2022 18.90 -0.54 -2.78% 19.44 19.71 18.78
Nov 1, 2022 19.58 -0.09 -0.46% 19.67 20.20 19.25

Core Laboratories Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 590.232 647.819 700.846 668.21 487.267 470.252
Revenue 590.232 647.819 700.846 668.21 487.267 470.252
Cost of Revenue, Total 437.503 464.958 496.964 495.579 374.767 367.896
Gross Profit 152.729 182.861 203.882 172.631 112.5 102.356
Total Operating Expense 502.781 537.851 582.224 571.526 564.072 424.99
Selling/General/Admin. Expenses, Total 39.39 47.737 62.91 48.023 34.033 44.173
Depreciation / Amortization 26.288 24.524 23.087 22.605 20.867 18.516
Interest Expense (Income) - Net Operating 1.776 0.951 2.598 1.725 1.16 -0.228
Unusual Expense (Income) -0.618 0.799 -0.455 -1.737 135.268 -1.439
Other Operating Expenses, Total -1.558 -1.118 -2.88 5.331 -2.023 -3.928
Operating Income 87.451 109.968 118.622 96.684 -76.805 45.262
Interest Income (Expense), Net Non-Operating -11.572 -10.734 -13.328 -14.69 -14.372 -9.152
Net Income Before Taxes 75.879 99.234 105.294 81.994 -91.177 36.11
Net Income After Taxes 65.024 80.985 79.847 94.284 -97.073 20.219
Minority Interest 0.036 0.029 -0.263 -0.134 -0.14 -0.492
Net Income Before Extra. Items 65.06 81.014 79.584 94.15 -97.213 19.727
Total Extraordinary Items -1.165 2.111 -0.058 7.833 -0.424 0
Net Income 63.895 83.125 79.526 101.983 -97.637 19.727
Income Available to Common Excl. Extra. Items 65.06 81.014 79.584 94.15 -97.213 19.727
Income Available to Common Incl. Extra. Items 63.895 83.125 79.526 101.983 -97.637 19.727
Diluted Net Income 63.895 83.125 79.526 101.983 -97.637 19.727
Diluted Weighted Average Shares 43.67 44.264 44.474 44.646 44.477 46.69
Diluted EPS Excluding Extraordinary Items 1.48981 1.83025 1.78945 2.10881 -2.18569 0.42251
Dividends per Share - Common Stock Primary Issue 2.2 2.2 2.2 2.2 0.28 0.04
Diluted Normalized EPS 1.47768 1.84498 1.78169 2.08352 -0.20885 0.40525
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 108.383 118.745 117.985 125.139 115.3
Revenue 108.383 118.745 117.985 125.139 115.3
Cost of Revenue, Total 84.15 93.841 92.918 96.987 96.952
Gross Profit 24.233 24.904 25.067 28.152 18.348
Total Operating Expense 96.761 105.945 111.345 110.939 115.691
Selling/General/Admin. Expenses, Total 8.461 9.67 15.115 10.927 12.545
Depreciation / Amortization 4.871 4.751 4.496 4.398 4.557
Interest Expense (Income) - Net Operating -0.408 0.352 -0.14 -0.032 -0.417
Unusual Expense (Income) -0.072 -1.059 -0.231 -0.077 3.175
Other Operating Expenses, Total -0.241 -1.61 -0.813 -1.264 -1.121
Operating Income 11.622 12.8 6.64 14.2 -0.391
Interest Income (Expense), Net Non-Operating -1.363 -2.53 -2.669 -2.59 -2.644
Net Income Before Taxes 10.259 10.27 3.971 11.61 -3.035
Net Income After Taxes 8.207 8.217 1.009 2.787 -1.839
Minority Interest -0.102 -0.157 -0.135 -0.099 -0.049
Net Income Before Extra. Items 8.105 8.06 0.874 2.688 -1.888
Total Extraordinary Items 0 0 0 0
Net Income 8.105 8.06 0.874 2.688 -1.888
Income Available to Common Excl. Extra. Items 8.105 8.06 0.874 2.688 -1.888
Income Available to Common Incl. Extra. Items 8.105 8.06 0.874 2.688 -1.888
Diluted Net Income 8.105 8.06 0.874 2.688 -1.888
Diluted Weighted Average Shares 45.964 47.103 47.125 46.261 46.298
Diluted EPS Excluding Extraordinary Items 0.17633 0.17111 0.01855 0.05811 -0.04078
Dividends per Share - Common Stock Primary Issue 0.01 0.01 0.01 0.01 0.01
Diluted Normalized EPS 0.17508 0.15313 0.01536 0.05702 0.0038
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 186.461 207.427 230.977 221.237 165.848 189.055
Cash and Short Term Investments 14.764 14.4 13.116 11.092 13.806 17.703
Cash & Equivalents 14.764 14.4 13.116 11.092 13.806 17.703
Total Receivables, Net 120.755 140.605 143.15 138.106 92.867 106.741
Accounts Receivable - Trade, Net 114.329 133.097 129.157 131.579 83.192 96.83
Total Inventory 33.72 33.317 45.664 50.163 38.151 45.443
Prepaid Expenses 10.711 12.592 15.351 15.951 14.797 14.059
Other Current Assets, Total 6.511 6.513 13.696 5.925 6.227 5.109
Total Assets 573.052 584.812 648.827 774.673 568.579 580.853
Property/Plant/Equipment, Total - Net 129.882 123.098 122.917 199.203 181.678 172.339
Property/Plant/Equipment, Total - Gross 379.147 400.174 481.39 475.656 478.8
Accumulated Depreciation, Total -249.265 -277.257 -282.187 -293.978 -306.461
Goodwill, Net 179.044 179.044 219.412 213.425 99.445 99.445
Intangibles, Net 9.936 9.396 13.054 17.45 8.583 8.139
Long Term Investments 3.224 3.76
Other Long Term Assets, Total 64.505 65.847 58.707 123.358 113.025 111.875
Total Current Liabilities 104.023 100.576 102.547 111.594 89.75 90.782
Accounts Payable 33.72 41.697 41.155 35.611 23.028 29.726
Accrued Expenses 25.227 36.2 30.037 46.896 44.519 39.106
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 45.076 22.679 31.355 29.087 22.203 21.95
Total Liabilities 421.698 439.968 492.068 596.808 497.066 424.404
Total Long Term Debt 216.488 226.989 289.77 305.283 259.433 188.636
Long Term Debt 216.488 226.989 289.77 305.283 259.433 188.636
Deferred Income Tax 6.277 5.323 7.634 26.284 20.585 24.336
Minority Interest 3.943 3.888 4.141 4.275 4.06 4.552
Other Liabilities, Total 90.967 103.192 87.976 149.372 123.238 116.098
Total Equity 151.354 144.844 156.759 177.865 71.513 156.449
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 1.148 1.148 1.148 1.148 1.148 1.188
Additional Paid-In Capital 52.85 54.463 57.438 51.872 41.184 101.12
Retained Earnings (Accumulated Deficit) 187.957 173.855 156.13 160.539 50.456 68.349
Treasury Stock - Common -80.773 -76.269 -52.501 -29.364 -14.075 -4.075
Unrealized Gain (Loss) -9.769 -8.703 -6.243 -5.64 -1.825 -4.538
Other Equity, Total -0.059 0.35 0.787 -0.69 -5.375 -5.595
Total Liabilities & Shareholders’ Equity 573.052 584.812 648.827 774.673 568.579 580.853
Total Common Shares Outstanding 44.1513 44.1842 44.3168 44.4656 44.5728 46.3494
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 185.817 201.149 187.245 189.055 202.192
Cash and Short Term Investments 27.806 33.617 19.05 17.703 22.037
Cash & Equivalents 27.806 33.617 19.05 17.703 22.037
Total Receivables, Net 99.941 110.168 107.77 106.741 113.54
Accounts Receivable - Trade, Net 86.567 93.217 95.297 96.83 98.9
Total Inventory 39.117 38.946 44.056 45.443 48.224
Prepaid Expenses 13.107 12.231 11.022 14.059 13.611
Other Current Assets, Total 5.846 6.187 5.347 5.109 4.78
Total Assets 584.446 598.425 586.279 580.853 584.918
Property/Plant/Equipment, Total - Net 183.786 178.88 178.115 172.339 170.094
Goodwill, Net 99.445 99.445 99.445 99.445 99.445
Intangibles, Net 8.423 8.317 8.246 8.139 7.979
Other Long Term Assets, Total 106.975 110.634 113.228 111.875 105.208
Total Current Liabilities 85.533 90.854 92.953 90.782 99.762
Accounts Payable 25.5 30.383 35.015 29.726 34.405
Accrued Expenses 39.917 39.857 39.536 39.106 43.929
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 20.116 20.614 18.402 21.95 21.428
Total Liabilities 442.562 448.4 429.718 424.404 423.133
Total Long Term Debt 208.166 208.305 188.463 188.636 189.807
Long Term Debt 208.166 208.305 188.463 188.636 189.807
Deferred Income Tax 20.48 20.677 23.837 24.336 23.27
Minority Interest 4.162 4.319 4.453 4.552 4.601
Other Liabilities, Total 124.221 124.245 120.012 116.098 105.693
Total Equity 141.884 150.025 156.561 156.449 161.785
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 1.188 1.188 1.188 1.188 1.188
Additional Paid-In Capital 103.358 98.255 106.027 101.12 107.088
Retained Earnings (Accumulated Deficit) 58.115 65.712 66.123 68.349 65.998
Treasury Stock - Common -12.916 -4.992 -7.084 -4.075 -5.736
Unrealized Gain (Loss) -2.486 -4.763 -4.318 -4.538 -1.158
Other Equity, Total -5.375 -5.375 -5.375 -5.595 -5.595
Total Liabilities & Shareholders’ Equity 584.446 598.425 586.279 580.853 584.918
Total Common Shares Outstanding 46.2405 46.3255 46.26 46.3494 46.2837
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 65.024 80.985 79.847 94.284 -97.073 20.219
Cash From Operating Activities 131.887 124.271 111.827 89.527 57.868 36.579
Cash From Operating Activities 26.872 24.524 23.087 22.605 20.867 18.516
Deferred Taxes -14.385 9.015 1.832 -36.345 -12.216 6.012
Non-Cash Items 19.174 18.232 36.052 16.69 140.351 12.395
Cash Taxes Paid 12.181 24.314 31.928 13.804 21.325 9.066
Cash Interest Paid 11.248 10.527 11.499 13.631 11.669 10.477
Changes in Working Capital 35.202 -8.485 -28.991 -7.707 5.939 -20.563
Cash From Investing Activities -14.721 -20.557 -70.639 -5.677 7.851 -10.223
Capital Expenditures -11.704 -19.154 -22.931 -22.269 -11.88 -13.539
Other Investing Cash Flow Items, Total -3.017 -1.403 -47.708 16.592 19.731 3.316
Cash From Financing Activities -124.896 -104.078 -42.472 -85.874 -63.005 -22.459
Financing Cash Flow Items -2.548 -0.026 -1.77 0.008 -1.766 -1.369
Total Cash Dividends Paid -95.145 -97.143 -97.251 -97.574 -12.446 -1.834
Issuance (Retirement) of Stock, Net 190.041 -16.909 -7.451 -3.308 -2.793 51.744
Issuance (Retirement) of Debt, Net -217.244 10 64 15 -46 -71
Net Change in Cash -7.73 -0.364 -1.284 -2.024 2.714 3.897
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 8.207 16.424 17.432 20.219 -1.839
Cash From Operating Activities 7.987 17.473 29.425 36.579 5.29
Cash From Operating Activities 4.871 9.622 14.118 18.516 4.557
Deferred Taxes 4.704 2.732 3.058 6.012 1.698
Non-Cash Items 4.269 7.405 11.707 12.395 8.529
Cash Taxes Paid 1.429 5.069 7.27 9.066 2.691
Cash Interest Paid 3.739 5.489 8.841 10.477 2.508
Changes in Working Capital -14.064 -18.71 -16.89 -20.563 -7.655
Cash From Investing Activities -1.07 -3.378 -6.529 -10.223 0.428
Capital Expenditures -2.772 -5.657 -8.789 -13.539 -2.297
Other Investing Cash Flow Items, Total 1.702 2.279 2.26 3.316 2.725
Cash From Financing Activities 7.083 5.716 -17.652 -22.459 -1.384
Financing Cash Flow Items -0.439 -0.483 -1.369 -1.369 -0.001
Total Cash Dividends Paid -0.446 -0.909 -1.372 -1.834 -0.463
Issuance (Retirement) of Stock, Net 58.968 58.108 56.089 51.744 -1.92
Issuance (Retirement) of Debt, Net -51 -51 -71 -71 1
Net Change in Cash 14 19.811 5.244 3.897 4.334

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Core Laboratories Company profile

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Core Laboratories N.V. revenues decreased 3% to $470.3M. Net income before extraordinary items totaled $19.7M vs. loss of $97.2M. Revenues reflect Reservoir Description segment decrease of 12% to $313.6M, United States segment decrease of 7% to $148.2M, Other Countries segment decrease of 2% to $322.1M. Net Income reflects Production Enhancement segment income totaling $15.2M vs. loss of $133.4M.

Equity composition

Common Stock EUR.02 Par 3/11, 200M auth., 49,739,912 issd., less 4,164,536 shs. in Treas. @ $261.4M. Insiders own 1.35%. IPO 9/95,2.8M shs @ $12 by Jefferies. PO 11/97, 300.8M. shs(1.4M by Co.) @ $36 by BTAB. 12/97, 2-for-1 stock split. FY'02-03 fincls. & '03 Qs are restated for discont. ops. 07/10, 2-for-1 stock split.

Industry: Oil Related Services and Equipment (NEC)

Van Heuven Goedhartlaan 7 B
AMSTELVEEN
NOORD-HOLLAND 1181 LE
NL

Income Statement

People also watch

US100

11,537.40 Price
+0.350% 1D Chg, %
Long position overnight fee -0.0167%
Short position overnight fee 0.0059%
Overnight fee time 22:00 (UTC)
Spread 1.8

Natural Gas

7.23 Price
-0.360% 1D Chg, %
Long position overnight fee 0.0593%
Short position overnight fee -0.0879%
Overnight fee time 22:00 (UTC)
Spread 0.005

BTC/USD

16,831.30 Price
+2.200% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 66.00

Oil - Crude

80.53 Price
+1.950% 1D Chg, %
Long position overnight fee -0.0106%
Short position overnight fee -0.0029%
Overnight fee time 22:00 (UTC)
Spread 0.04

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading